GBA1 and Parkinson disease: Reduced GCase activity is observed in PD patient tissues and in in vitro cellular systems harboring mutations in GBA gene, as well as, in the brain, cerebrospinal fluid (CSF) and blood from sporadic PD patients with no GBA mutations [4, 8–17].